Background Inconsistent monitoring of prostate-specific antigen in patients receiving 5-alpha reductase inhibitors for lower urinary tract symptoms/benign prostate enlargement may affect prostate cancer outcomes.
Juan Manuel Palacios +7 more
doaj +1 more source
Variation in general practice prostate-specific antigen testing and prostate cancer outcomes: An ecological study [PDF]
Peter Hjertholm +6 more
openalex +1 more source
Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of Prostate Cancer: A Systematic Review and Meta-Analysis [PDF]
Sungmin Woo +8 more
openalex +1 more source
More on "hook effects" in immunometric assays for prostate-specific antigen. [PDF]
G. Bodor +4 more
openalex +1 more source
Epidemiological Study of Patients with Prostate Cancer in South of Iraq
The present study was designed to investigate some epidemiological and serological study, in a sample of Thi-Qar, Basarh, Missan provinces south of Iraq.
Manal Badi Salih Al-Tmemi
doaj
The Prostate Gland and PSA (Prostate Specific Antigen) [PDF]
Serfa Faja, Amir Shoshi
openalex +1 more source
The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostate carcinoma [PDF]
Robin T. Vollmer
openalex +1 more source
Background: Previous studies had shown that patients with breast cancer have a high level of prostate-specific antigen (PSA). But there was not any study about the role of prostate-specific antigen in detection of breast cancer.
Gholamreza Mohajeri +2 more
doaj
Downregulation and Prognostic Performance of MicroRNA 224 Expression in Prostate Cancer [PDF]
The extensive use of prostate-specific antigen as a general prostate cancer biomarker has introduced the hazards of overdiagnosis and overtreatment. Recent studies have revealed the immense biomarker capacity of microRNAs (miRNAs) in prostate cancer. The
Mavridis, Konstantinos +2 more
core +1 more source

